139 related articles for article (PubMed ID: 10637495)
1. Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors.
Gu ZJ; De Vos J; Rebouissou C; Jourdan M; Zhang XG; Rossi JF; Wijdenes J; Klein B
Leukemia; 2000 Jan; 14(1):188-97. PubMed ID: 10637495
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.
Nishimoto N; Ogata A; Shima Y; Tani Y; Ogawa H; Nakagawa M; Sugiyama H; Yoshizaki K; Kishimoto T
J Exp Med; 1994 Apr; 179(4):1343-7. PubMed ID: 8145046
[TBL] [Abstract][Full Text] [Related]
3. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130.
Zhang XG; Gu JJ; Lu ZY; Yasukawa K; Yancopoulos GD; Turner K; Shoyab M; Taga T; Kishimoto T; Bataille R
J Exp Med; 1994 Apr; 179(4):1337-42. PubMed ID: 8145045
[TBL] [Abstract][Full Text] [Related]
4. Dimerization and activation of the common transducing chain (gp130) of the cytokines of the IL-6 family by mAb.
Autissier P; De Vos J; Liautard J; Tupitsyn N; Jacquet C; Chavdia N; Klein B; Brochier J; Gaillard JP
Int Immunol; 1998 Dec; 10(12):1881-9. PubMed ID: 9885909
[TBL] [Abstract][Full Text] [Related]
5. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
Westendorf JJ; Jelinek DF
J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies.
Wijdenes J; Heinrich PC; Müller-Newen G; Roche C; Gu ZJ; Clément C; Klein B
Eur J Immunol; 1995 Dec; 25(12):3474-81. PubMed ID: 8566040
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.
Liautard J; Sun RX; Cotte N; Gaillard JP; Mani JC; Klein B; Brochier J
Cytokine; 1997 Apr; 9(4):233-41. PubMed ID: 9112331
[TBL] [Abstract][Full Text] [Related]
8. Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survival.
Burger R; Bakker F; Guenther A; Baum W; Schmidt-Arras D; Hideshima T; Tai YT; Shringarpure R; Catley L; Senaldi G; Gramatzki M; Anderson KC
Br J Haematol; 2003 Dec; 123(5):869-78. PubMed ID: 14632778
[TBL] [Abstract][Full Text] [Related]
9. Activation of the gp130 signaling pathway by monoclonal antibodies directed against the gp130 molecule.
Autissier P; Liautard J; Brochier J; Gaillard JP
Eur J Immunol; 1997 Mar; 27(3):794-7. PubMed ID: 9079824
[TBL] [Abstract][Full Text] [Related]
10. A gp130 interleukin-6 transducer-dependent SCID model of human multiple myeloma.
Rebouissou C; Wijdenes J; Autissier P; Tarte K; Costes V; Liautard J; Rossi JF; Brochier J; Klein B
Blood; 1998 Jun; 91(12):4727-37. PubMed ID: 9616171
[TBL] [Abstract][Full Text] [Related]
11. Update of gp130 cytokines in multiple myeloma.
Klein B
Curr Opin Hematol; 1998 May; 5(3):186-91. PubMed ID: 9664158
[TBL] [Abstract][Full Text] [Related]
12. In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway.
Chatterjee M; Hönemann D; Lentzsch S; Bommert K; Sers C; Herrmann P; Mathas S; Dörken B; Bargou RC
Blood; 2002 Nov; 100(9):3311-8. PubMed ID: 12384432
[TBL] [Abstract][Full Text] [Related]
13. IFN-alpha is a survival factor for human myeloma cells and reduces dexamethasone-induced apoptosis.
Ferlin-Bezombes M; Jourdan M; Liautard J; Brochier J; Rossi JF; Klein B
J Immunol; 1998 Sep; 161(6):2692-9. PubMed ID: 9743325
[TBL] [Abstract][Full Text] [Related]
14. Expression and production of interleukin 10 in human myeloma cell lines.
Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 and Gp130 cytokines in human multiple myeloma.
Klein B; Lu ZY; Gu ZJ; Costes V; Jourdan M; Rossi JF
Leuk Lymphoma; 1999 Jun; 34(1-2):63-70. PubMed ID: 10350333
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-21 is a growth and survival factor for human myeloma cells.
Brenne AT; Ro TB; Waage A; Sundan A; Borset M; Hjorth-Hansen H
Blood; 2002 May; 99(10):3756-62. PubMed ID: 11986233
[TBL] [Abstract][Full Text] [Related]
17. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
[TBL] [Abstract][Full Text] [Related]
18. Anti-gp130 transducer monoclonal antibodies specifically inhibiting ciliary neurotrophic factor, interleukin-6, interleukin-11, leukemia inhibitory factor or oncostatin M.
Gu ZJ; Wijdenes J; Zhang XG; Hallet MM; Clement C; Klein B
J Immunol Methods; 1996 Mar; 190(1):21-7. PubMed ID: 8601708
[TBL] [Abstract][Full Text] [Related]
19. How does interleukin-6 affect the membrane expressions of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2?
Kovacs E
Biomed Pharmacother; 2003 Dec; 57(10):489-94. PubMed ID: 14637393
[TBL] [Abstract][Full Text] [Related]
20. Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells.
Burger R; Neipel F; Fleckenstein B; Savino R; Ciliberto G; Kalden JR; Gramatzki M
Blood; 1998 Mar; 91(6):1858-63. PubMed ID: 9490667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
